Anthem Biosciences Limited (BOM:544449)

India · Delayed Price · Currency is INR

755.35

-4.75 (-0.62%)

At close: Jun 1, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Contract Research Development & Manufacturing Services (CRDMO)	17.73B	13.06B	8.98B	8.08B	9.47B
Contract Research Development & Manufacturing Services (CRDMO) Growth	35.79%	45.44%	11.08%	-14.69%	-4.94%
Speciality Ingredients	3.52B	3.38B	3.36B	2.49B	2.84B
Speciality Ingredients Growth	3.87%	0.68%	35.11%	-12.40%	165.96%
R & D Services	-	2.01B	1.86B	-	-
R & D Services Growth	-	8.09%	-	-	-
Total	21.24B	18.45B	14.19B	10.57B	12.31B
Total Growth	15.17%	29.96%	34.29%	-14.16%	11.60%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
North America (USA)	4.87B	4.29B	5.00B	5.18B
North America (USA) Growth	13.70%	-14.31%	-3.38%	-8.19%
Europe	10.07B	6.13B	3.06B	4.60B
Europe Growth	64.20%	100.35%	-33.38%	60.58%
India	3.06B	3.10B	2.13B	2.32B
India Growth	-1.32%	45.34%	-8.08%	45.05%
Rest of Asia & Others	443.66M	676.71M	374.95M	222.01M
Rest of Asia & Others Growth	-34.44%	80.48%	68.89%	-
Total	18.45B	14.19B	10.57B	12.31B
Total Growth	29.96%	34.29%	-14.16%	11.60%

Source: S&P Global Market Intelligence.